Abstract:Mutations in the BRCA1 or BRCA2 genes predispose to a wide spectrum of familial cancers. The functions of the proteins encoded by BRCA1 and BRCA2 remain to be elucidated, but their interaction and colocalization with hRAD51 suggest a role in homologous recombination and DNA double-strand break (DSB) repair. The role of BRCA1 and BRCA2 in the rejoining of ionizing radiation (IR)-induced DNA DSBs, which may represent a step in the overall process of repair, remains uncertain because recent reports provide conflicting results. Because elucidation of the role of these proteins in DNA DSB rejoining is important for their functional characterization, we reexamined this end point in cells with mutations in either BRCA1 or BRCA2. We show that two pancreatic carcinoma cell lines known to have either wild-type (BxPC3) or mutant forms (Capan-1) of BRCA2 rejoin IR-induced DNA DSBs to a similar extent following biphasic kinetics characterized by a fast and a slow component. Importantly, inactivation of DNA-dependent protein kinase (DNA-PK) by wortmannin generates similar shifts from the fast to the slow component of rejoining in BRCA2-proficient and BRCA2-deficient cells. This suggests that the functioning of either the fast, DNA-PK-dependent component or the slow, DNA-PK-independent component of rejoining is not affected by mutations in BRCA2. Also, a human breast cancer cell line with mutated BRCA1 shows normal rejoining of IR-induced DNA DSBs and levels of inhibition by wortmannin commensurate with the degree of DNA-PK inhibition. These observations fail to confirm a direct role for BRCA1 or BRCA2 in the rejoining of IR-induced DSBs in the genome of human tumor cells and, as a result, an involvement in nonhomologous end-joining. They are in line with similar observations with mutants deficient in genes implicated in homologous recombination and support the view that the radiosensitivity to killing of cells deficient in BRCA1 or BRCA2 derives from defects in this repair pathway.

Association of BRCA1 with the Hrad50-Hmre11-p95 Complex and the DNA Damage Response

RAP80-directed Tuning of BRCA1 Homologous Recombination Function at Ionizing Radiation-Induced Nuclear Foci.

Molecular Functions of BRCA1 in the DNA Damage Response

Expression of BRC Repeats in Breast Cancer Cells Disrupts the BRCA2-Rad51 Complex and Leads to Radiation Hypersensitivity and Loss of G(2)/M Checkpoint Control.

Homologous Recombination is Independently Regulated by BRCA1 and P53

Nonhomologous End-Joining of Ionizing Radiation-Induced DNA Double-Stranded Breaks in Human Tumor Cells Deficient in BRCA1 or BRCA2.

Brca1 Facilitates Microhomology-Mediated End Joining of Dna Double Strand Breaks

BRCA1: a Key Player at Multiple Stages of Homologous Recombination in DNA Double-Strand Break Repair

BRCA1–BARD1 Promotes RAD51-mediated Homologous DNA Pairing

Deficiency of Human BRCA2 Leads to Impaired Homologous Recombination but Maintains Normal Nonhomologous End Joining

Progress in role of breast cancer susceptibility gene 1 in DNA damage repair

A phosphorylation-deubiquitination cascade regulates the BRCA2-RAD51 axis in homologous recombination.

Regulation of BRCC, a holoenzyme complex containing BRCA1 and BRCA2, by a signalosome-like subunit and its role in DNA repair.

Brca1-Associated Proteins: Novel Targets For Breast Cancer Radiation Therapy

Brcc36 is Essential for Ionizing Radiation-Induced Brca1 Phosphorylation and Nuclear Foci Formation

P53 Suppresses Hyper-Recombination by Modulating BRCA1 Function.

Cell Cycle-dependent Complex Formation of BRCA1·CtIP·MRN is Important for DNA Double-strand Break Repair

BRCA1 Interaction with Non-Canonical DNA Structures: Insights into Genome Maintenance and Disease Mechanisms

Hypersensitivity of Brca1-Deficient Mef to the Dna Interstrand Crosslinking Agent Mitomycin C is Associated with Defect in Homologous Recombination Repair and Aberrant S-Phase Arrest

The Role of BRCA1 in DNA Damage Response

CCDC98 is a BRCA1-BRCT Domain–binding Protein Involved in the DNA Damage Response